Welcome to LookChem.com Sign In|Join Free

CAS

  • or

65428-04-8

65428-04-8

Post Buying Request

65428-04-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

65428-04-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 65428-04-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,4,2 and 8 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 65428-04:
(7*6)+(6*5)+(5*4)+(4*2)+(3*8)+(2*0)+(1*4)=128
128 % 10 = 8
So 65428-04-8 is a valid CAS Registry Number.
InChI:InChI=1/C16H16O4/c1-20-13-7-8-14(16(19)10-13)15(18)9-4-11-2-5-12(17)6-3-11/h2-3,5-8,10,17,19H,4,9H2,1H3

65428-04-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(2-hydroxy-4-methoxyphenyl)-3-(4-hydroxyphenyl)propan-1-one

1.2 Other means of identification

Product number -
Other names 4'-O-Methyldavidigenin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:65428-04-8 SDS

65428-04-8Downstream Products

65428-04-8Relevant articles and documents

COMPOSITIONS AND METHODS OF TREATING UPS-ASSOCIATED DISEASES

-

, (2022/01/24)

The present invention relates to methods for treating a disease characterized by aberrations in the ubiquitin/proteasome system (UPS).

Synthesis, anticancer, structural, and computational docking studies of 3-benzylchroman-4-one derivatives

Simon, Lalitha,Abdul Salam, Abdul Ajees,Madan Kumar,Shilpa,Srinivasan,Byrappa

, p. 5284 - 5290 (2017/10/30)

A series of 3-Benzylchroman-4-ones were synthesized and screened for anticancer activity by MTT assay. The compounds were evaluated against two cancerous cell lines BT549 (human breast carcinoma), HeLa (human cervical carcinoma), and one noncancerous cell

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 65428-04-8